Gregory Piazza1. Show Affiliations » 1. From the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. gpiazza@partners.org.
Abstract
Entities: Disease Species
Mesh: See more » AdultAgedAnticoagulants/therapeutic useFemaleHumansMaleMass ScreeningMorpholines/therapeutic useMutation/geneticsProthrombin/geneticsRecurrenceRisk FactorsRivaroxabanThiophenes/therapeutic useThrombophilia/complicationsThrombophilia/diagnosisThrombophilia/geneticsTreatment OutcomeVenous Thrombosis/diagnosisVenous Thrombosis/drug therapyVenous Thrombosis/epidemiologyWarfarin/therapeutic useWomen's Health
Substances: See more » AnticoagulantsMorpholinesThiophenesWarfarinProthrombinRivaroxaban
Year: 2014 PMID: 25024124 DOI: 10.1161/CIRCULATIONAHA.113.007664
Source DB: PubMed Journal: Circulation ISSN: 0009-7322 Impact factor: 29.690